Foxp3+CD25(high) CD4+ regulatory T cells from indeterminate patients with Chagas disease can suppress the effector cells and cytokines and reveal altered correlations with disease severity.
about
The Dialogue of the Host-Parasite Relationship: Leishmania spp. and Trypanosoma cruzi InfectionModulation of Trypanosoma cruzi-specific T-cell responses after chemotherapy for chronic Chagas diseaseRegulatory T Cell and Forkhead Box Protein 3 as Modulators of Immune HomeostasisAcute chagas disease: new global challenges for an old neglected diseaseMyocardial gene expression of T-bet, GATA-3, Ror-γt, FoxP3, and hallmark cytokines in chronic Chagas disease cardiomyopathy: an essentially unopposed TH1-type response.Immunoregulatory networks in human Chagas disease.Tc52 amino-terminal-domain DNA carried by attenuated Salmonella enterica serovar Typhimurium induces protection against a Trypanosoma cruzi lethal challenge.IL-10 inhibits the NF-κB and ERK/MAPK-mediated production of pro-inflammatory mediators by up-regulation of SOCS-3 in Trypanosoma cruzi-infected cardiomyocytes.Plasma cytokine expression is associated with cardiac morbidity in chagas disease.Immunoregulatory mechanisms in Chagas disease: modulation of apoptosis in T-cell mediated immune responses.The role of interleukin 17-mediated immune response in Chagas disease: High level is correlated with better left ventricular functionCD4+ CD25+ FOXP3+ Treg cells induced by rSSP4 derived from T. cruzi amastigotes increase parasitemia in an experimental Chagas disease model.CpG and interleukin-15 synergize to enhance IFN-γ production by activated CD8+ T cellsHigh interleukin 17 expression is correlated with better cardiac function in human Chagas disease.Matrix metalloproteinases 2 and 9 are differentially expressed in patients with indeterminate and cardiac clinical forms of Chagas diseaseChagas disease: still many unsolved issues.Treatment Success in Trypanosoma cruzi Infection Is Predicted by Early Changes in Serially Monitored Parasite-Specific T and B Cell ResponsesParticipation of TLR2 and TLR4 in Cytokines Production by Patients with Symptomatic and Asymptomatic Chronic Chagas Disease.Synergic and antagonistic relationship between MMP-2 and MMP-9 with fibrosis and inflammation in Chagas' cardiomyopathy.Administration of a nondepleting anti-CD25 monoclonal antibody reduces disease severity in mice infected with Trypanosoma cruziImmunoregulatory actions of melatonin and zinc during chronic Trypanosoma cruzi infection.Depletion of regulatory T cells decreases cardiac parasitosis and inflammation in experimental Chagas disease.Trans-sialidase-based vaccine candidate protects against Trypanosoma cruzi infection, not only inducing an effector immune response but also affecting cells with regulatory/suppressor phenotype.Increase in the expression of CD4 + CD25+ lymphocytic T cells in the indeterminate clinical form of human Chagas disease after stimulation with recombinant antigens of Trypanosoma cruzi.Ebi3 Prevents Trypanosoma cruzi-Induced Myocarditis by Dampening IFN-γ-Driven InflammationIdentification of phenotypic markers of B cells from patients with Chagas disease.Role of T. cruzi exposure in the pattern of T cell cytokines among chronically infected HIV and Chagas disease patients.Specific activation of CD4- CD8- double-negative T cells by Trypanosoma cruzi-derived glycolipids induces a proinflammatory profile associated with cardiomyopathy in Chagas patients.CD86 Expression by Monocytes Influences an Immunomodulatory Profile in Asymptomatic Patients with Chronic Chagas Disease.Granulocyte-Colony Stimulating Factor-Overexpressing Mesenchymal Stem Cells Exhibit Enhanced Immunomodulatory Actions Through the Recruitment of Suppressor Cells in Experimental Chagas Disease Cardiomyopathy.Plasmodium vivax infection impairs regulatory T cell suppressive function during acute malariaThe Unsolved Jigsaw Puzzle of the Immune Response in Chagas DiseaseLimited Foxp3 Regulatory T Cells Response During Acute Infection Is Required to Allow the Emergence of Robust Parasite-Specific CD8 T Cell Immunity
P2860
Q26829884-C3C9C8DA-9A22-4015-A644-56C0A9A666B4Q28083346-5C4F6A4C-E1FC-4FCE-9C98-5053CBFEFB5EQ33729446-FACD055E-6699-4BA2-9457-A4E1A618815FQ33981753-A1F2F800-28F9-44CD-9FF9-05DFFA83DB10Q34053139-5959A77A-961B-4057-9107-5075C9BD1E68Q34084644-E1E2256E-A575-4AFD-B745-ADD42A243772Q34298752-DD1AD253-00A6-471C-817B-1F5D45892AD5Q35048439-4429D36E-8CB5-493F-ACF0-A63746914CE3Q35112727-FA999DFB-84CE-4E7D-8C04-ADF5BB17EAD0Q36006382-1FC09BBD-990B-458D-867E-BEBA8F9E1F7DQ36302693-B990D3C4-30DA-44CB-8FE7-0B4A294D67CDQ36665012-446B6EFF-837E-487D-B22A-71284B7CD793Q36665239-4BD0EB29-CECB-47C0-8B8A-E38331E3ADA3Q36727275-588CD38A-C51F-4F70-94F1-A24CAAF2CFD7Q37264609-5B99EA50-28E5-43FD-A86B-6CC4827F5E4AQ38238078-7CD20DC3-F1A3-4FEC-ACF7-4D9EC151ABCBQ38871286-743B3D1D-D70F-4D02-8926-232931A098F8Q39244146-024D6A1F-FC67-4433-B53D-B0606FD9F042Q39329438-D9A824BE-518B-43D1-B3E0-74280DA4AE99Q39829243-7AC22471-1288-431A-9556-9D0878D10882Q41528104-AFF35C7F-4FC6-4869-A89A-A549BBA48CCFQ41552272-DBF7AC6F-0BC1-48B8-8D67-F5EA47A44AA7Q41709177-8CE69795-7CCB-4F9E-A3C6-E2A4FC8507EDQ41745518-EAA9E1BC-B318-435D-9CDC-5A0603071BC6Q42369872-25764984-0490-44A4-AAF1-E043F3B6DA09Q45341357-30049019-4A99-4313-BD06-78C6FBFA1FB9Q47157691-90D59B5B-5A60-443E-9F82-051C0251FC3CQ48099205-B5C55C4E-DCA5-4088-B5C4-A390343AB04CQ55364024-744A7338-A113-48A8-8DBF-FBDD611D73B9Q55709087-BFE3061B-D491-44BF-A7DA-D07BBBF7E0A6Q56363494-EAFC9155-6CD7-4869-B092-BCC90A9502EFQ58705710-A8B90CDE-B71E-4AEA-B0F8-71A8D63764B4Q59136942-9CB9EE25-108D-4D7C-94BB-0212E442340E
P2860
Foxp3+CD25(high) CD4+ regulatory T cells from indeterminate patients with Chagas disease can suppress the effector cells and cytokines and reveal altered correlations with disease severity.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Foxp3+CD25
@nl
Foxp3+CD25(high) CD4+ regulato ...... lations with disease severity.
@en
type
label
Foxp3+CD25
@nl
Foxp3+CD25(high) CD4+ regulato ...... lations with disease severity.
@en
prefLabel
Foxp3+CD25
@nl
Foxp3+CD25(high) CD4+ regulato ...... lations with disease severity.
@en
P2093
P1433
P1476
Foxp3+CD25(high) CD4+ regulato ...... elations with disease severity
@en
P2093
A T Chaves
A Teixeira-Carvalho
F F de Araújo
K S Ferreira
M C P Nunes
M O C Rocha
M P S Damasio
R C G Fares
T S Keesen
P304
P356
10.1016/J.IMBIO.2012.04.008
P577
2012-05-09T00:00:00Z